Prevention of αIIbβ3 activation by non-steroidal antiinflammatory drugs

被引:15
作者
Domínguez-Jiménez, C
Díaz-González, F
González-Alvaro, I
Cesar, JM
Sánchez-Madrid, F
机构
[1] Univ Autonoma Madrid, Hosp Princesa, Serv Inmunol, Madrid 28006, Spain
[2] Univ Autonoma Madrid, Hosp Princesa, Serv Reumatol, Madrid 28006, Spain
[3] Hosp Ramon y Cajal, Serv Hematol, E-28034 Madrid, Spain
关键词
non-steroidal antiinflammatory drug; alpha IIb beta 3; platelet activation;
D O I
10.1016/S0014-5793(99)00236-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have studied the effect of non-steroidal antiinflammatory drugs (NSAIDs) on alpha IIb beta 3 integrin activation and platelet aggregation. NSAIDs such as meloxicam, piroxicam, indomethacin and aspirin, but not aceclofenac or diclofenac interfered with the activation state of alpha IIb beta 3, NSAIDs that inhibited alpha IIb beta 3 activation were also able both to partially inhibit platelet primary: aggregation and to accelerate platelet deaggregation. These effects of NSAIDs were not dependent on cyclooxygenase inhibition, The results obtained indicate that some NSAIDs exert a specific action on alpha IIb beta 3 activation, and pro,ide an additional mechanism that accounts for their beneficial effects in diseases in which platelet activation is involved. (C) 1999 Federation of European Biochemical Societies.
引用
收藏
页码:318 / 322
页数:5
相关论文
共 27 条
[1]   MODES OF ACTION OF ASPIRIN-LIKE DRUGS [J].
ABRAMSON, S ;
KORCHAK, H ;
LUDEWIG, R ;
EDELSON, H ;
HAINES, K ;
LEVIN, RI ;
HERMAN, R ;
RIDER, L ;
KIMMEL, S ;
WEISSMANN, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (21) :7227-7231
[2]   LOW-MOLECULAR-WEIGHT, NONPEPTIDE FIBRINOGEN RECEPTOR ANTAGONISTS [J].
ALIG, L ;
EDENHOFER, A ;
HADVARY, P ;
HURZELER, M ;
KNOPP, D ;
MULLER, M ;
STEINER, B ;
TRZECIAK, A ;
WELLER, T .
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (23) :4393-4407
[3]   ACTIVATION OF PHOSPHOLIPASE-A AND PHOSPHOLIPASE-C IN HUMAN-PLATELETS EXPOSED TO EPINEPHRINE - ROLE OF GLYCOPROTEIN-IIB GLYCOPROTEINS-IIIA AND DUAL ROLE OF EPINEPHRINE [J].
BANGA, HS ;
SIMONS, ER ;
BRASS, LF ;
RITTENHOUSE, SE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (23) :9197-9201
[4]   EXPOSURE OF PLATELET FIBRINOGEN RECEPTORS BY ADP AND EPINEPHRINE [J].
BENNETT, JS ;
VILAIRE, G .
JOURNAL OF CLINICAL INVESTIGATION, 1979, 64 (05) :1393-1401
[5]   A ROLE FOR PROSTAGLANDINS AND THROMBOXANES IN THE EXPOSURE OF PLATELET FIBRINOGEN RECEPTORS [J].
BENNETT, JS ;
VILAIRE, G ;
BURCH, JW .
JOURNAL OF CLINICAL INVESTIGATION, 1981, 68 (04) :981-987
[6]   Platelet GPIIb/IIIa antagonists: The first anti-integrin receptor therapeutics [J].
Coller, BS .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (07) :1467-1471
[7]   PLATELETS AND THROMBOLYTIC THERAPY [J].
COLLER, BS .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (01) :33-42
[8]   PREVENTION OF IN-VITRO NEUTROPHIL-ENDOTHELIAL ATTACHMENT THROUGH SHEDDING OF L-SELECTIN BY NONSTEROIDAL ANTIINFLAMMATORY DRUGS [J].
DIAZGONZALEZ, F ;
GONZALEZALVARO, I ;
CAMPANERO, MR ;
MOLLINEDO, F ;
DELPOZO, MA ;
MUNOZ, C ;
PIVEL, JP ;
SANCHEZMADRID, F .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (04) :1756-1765
[9]  
ELEMER GS, 1994, J IMMUNOL, V152, P5836
[10]  
FLESCHER E, 1991, J IMMUNOL, V146, P2553